The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127882851 12788285 1 I 20160919 20160920 20160928 20160928 EXP US-ROCHE-1832844 ROCHE 70.00 YR M Y 93.50000 KG 20160928 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127882851 12788285 1 PS Obinutuzumab OBINUTUZUMAB 1 Unknown U 125486
127882851 12788285 2 SS Obinutuzumab OBINUTUZUMAB 1 U 125486
127882851 12788285 3 SS REVLIMID LENALIDOMIDE 1 Oral 15 MG TOTAL BY MOUTH DAILY AT BEDTIME FOR 14 DAYS OF EACH CYCLE U 0 CAPSULE
127882851 12788285 4 SS REVLIMID LENALIDOMIDE 1 U 0
127882851 12788285 5 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown U 0
127882851 12788285 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 U 0
127882851 12788285 7 SS Doxorubicin DOXORUBICIN 1 Unknown U 0
127882851 12788285 8 SS Doxorubicin DOXORUBICIN 1 U 0
127882851 12788285 9 SS Vincristine VINCRISTINE 1 Unknown U 0
127882851 12788285 10 SS Vincristine VINCRISTINE 1 U 0
127882851 12788285 11 SS PREDNISONE. PREDNISONE 1 Oral TAKE 2 TABLETS (100 MG TOTAL) BY MOUTH DAILY FOR 5 DAYS U 0 50 MG TABLET
127882851 12788285 12 SS PREDNISONE. PREDNISONE 1 U 0
127882851 12788285 13 C ZYLOPRIM ALLOPURINOL 1 Oral 300 MG 0 TABLET
127882851 12788285 14 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown TAKE 1 ORAL ONCE A DAY IN THE MORNING ON AN EMPTY STOMACH 0 5 UG
127882851 12788285 15 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED 0 8 MG
127882851 12788285 16 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 0
127882851 12788285 17 C HEPARIN HEPARIN SODIUM 1 Intravenous drip 100 UNITS/ML?INJECT 2 ML (200 UNITS) INTO EACH LUMEN OF CENTRAL VONOUS CATHETER DAILY FOR 30 DAYS 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127882851 12788285 1 Hodgkin's disease
127882851 12788285 2 Diffuse large B-cell lymphoma
127882851 12788285 3 Diffuse large B-cell lymphoma
127882851 12788285 4 Hodgkin's disease
127882851 12788285 5 Diffuse large B-cell lymphoma
127882851 12788285 6 Hodgkin's disease
127882851 12788285 7 Diffuse large B-cell lymphoma
127882851 12788285 8 Hodgkin's disease
127882851 12788285 9 Diffuse large B-cell lymphoma
127882851 12788285 10 Hodgkin's disease
127882851 12788285 11 Diffuse large B-cell lymphoma
127882851 12788285 12 Hodgkin's disease
127882851 12788285 15 Nausea
127882851 12788285 16 Vomiting

Outcome of event

Event ID CASEID OUTC COD
127882851 12788285 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127882851 12788285 Anaemia
127882851 12788285 Electrolyte imbalance
127882851 12788285 Pneumonia
127882851 12788285 Pulmonary embolism
127882851 12788285 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127882851 12788285 3 20160906 0
127882851 12788285 11 20160705 0
127882851 12788285 13 20160630 0
127882851 12788285 14 20160602 0
127882851 12788285 17 20160705 0